Cargando…
An observational study of tocilizumab and TNF-α inhibitor use in a Japanese community hospital: different remission rates, similar drug survival and safety
Objective. To assess the effectiveness, drug survival and safety of tocilizumab compared with TNF-α inhibitors in clinical practice. Methods. Patients in the Cohort of Arthritis Biologic Users at Kameda Institute (CABUKI) registry who were on biologics during July 2003 to October 2010 were included....
Autores principales: | Yoshida, Kazuki, Tokuda, Yasuharu, Oshikawa, Hideto, Utsunomiya, Masako, Kobayashi, Tatsuo, Kimura, Makiko, Deshpande, Gautam A., Matsui, Kazuo, Kishimoto, Mitsumasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198907/ https://www.ncbi.nlm.nih.gov/pubmed/21890622 http://dx.doi.org/10.1093/rheumatology/ker295 |
Ejemplares similares
-
Response to 'Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study'
por: Yoshida, Kazuki, et al.
Publicado: (2011) -
Tocilizumab for faster and safer remission of Takayasu’s arteritis
por: Liao, Hua, et al.
Publicado: (2022) -
Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA)
por: Yamaguchi, Ken-ichi, et al.
Publicado: (2012) -
Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
por: Galeotti, C, et al.
Publicado: (2011) -
Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development
por: Collins, Jamie E., et al.
Publicado: (2020)